Blood thinner showdown: new drug tested in healthy volunteers
NCT ID NCT07067775
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 20 times
Summary
This study tested a new blood thinner called vicagrel against the standard drug clopidogrel in 18 healthy adults with a specific gene type. The goal was to see how the body processes each drug and how well they work. Participants took both drugs at different times, and researchers measured drug levels and effects. This was a Phase 1 trial, so it focused on safety and drug behavior, not on treating any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Hospital of Jilin University
Changchun, Jilin, China
Conditions
Explore the condition pages connected to this study.